Ads
-
Related paper
- DHP107, a novel oral paclitaxel formulation induces less peripheral neuropathic pain and pain-related molecular alteration than intravenous paclitaxel preparation in rat
- Development issues related todesigns in neuropathic pain in light of the European MedicinesAgency’s (EMA) Guideline for the treatment of pain
- Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update
- Neuropathic Pain Management in a Tertiary Care Oral Medicine Unit
- Neuropathic pain due to chronic idiopathic axonal neuropathy: fast pain reduction after topical phenytoin cream application
- Gene Therapy Targeting Chloride Homeostasis Reverses Cancer-Related Neuropathic Pain
- Relationship between psychological distress and physical symptoms of functional dyspepsia with the mediating role of pain related mental imagery, visceral sensitivity, pain catastrophizing and pain self-efficacy
- ASSESSMENT OF EFFICIENCY OF ALPHA-LIPOIC ACID AND IPIDACRINE HYDROCHLORIDE TREATMENT FOR PREVENTION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY USING THE EQ-5D 5L QUALITY OF LIFE QUESTIONNAIRE
- Molecular Inclusion Complexes of β-Cyclodextrin Derivatives Enhance Aqueous Solubility and Cellular Internalization of Paclitaxel: Preformulation and In vitro Assessments
- A Study to Assess the Incidence and Contributing Risk Factors of Peripheral Intravenous Therapy Related Complications among Patients Receiving Peripheral Intravenous Therapy in a Tertiary Care Hospital